Immther SPRL
Immther reported total assets of 25,533 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Immther shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -90 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immther's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 22 Sep 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
Immther's financial analysis
- Solvency-7.6%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Immther
Immther's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0534.958.661
- VAT number
- BE0534958661
- Peppol
- Registered · 0208:0534958661 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 29 May 2013
- Registered office
- 3050 Oud-Heverlee
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Immther (SPRL) has been based in Oud-Heverlee since 2013, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 1,377 € and equity of −1,946 €; its revenue is not published. Its solvency stands at -7.6%, below the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Immther
Companies in the same business, of comparable size and area, outside its group.
- Allsightsafrica Research and experimental development on natural sciences and engineering Orp-Jauche · balance sheet 30,275 €
- Biokey Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 2,606 €
- Biograbbit Research and experimental development on natural sciences and engineering Dendermonde · balance sheet 61,503 €
- Targeted Intelligence Strategic Orientation Research and experimental development on natural sciences and engineering Uccle · balance sheet 32,774 €
- Europharmedtech Research and experimental development on natural sciences and engineering Ganshoren · balance sheet 54,960 €
- Swanet Biotech Research and experimental development on natural sciences and engineering Gembloux · balance sheet 26,578 €
- PLT Bioconsult Research and experimental development on natural sciences and engineering Liège · balance sheet 32,499 €
- Shift Happens Research and experimental development on natural sciences and engineering Ghent · balance sheet 62,809 €
Frequently asked questions about Immther
What is the revenue of Immther?
Immther files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Immther?
In Belgium, the VAT number is the company number prefixed with BE: BE0534958661 for Immther, if the company is VAT-registered. Its company number (CBE) is 0534.958.661.
Where is the registered office of Immther?
According to the CBE register, the registered office of Immther is in 3050 Oud-Heverlee.
What is the equity of Immther?
At the close of the 2025 financial year, the equity of Immther amounts to -1,946 €, a solvency of -7.6% of total assets.
Who manages Immther?
The register lists 2 active mandates at Immther. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immther
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →